Cellular Dynamics to Present at Leerink Swann Global Healthcare Conference
February 06, 2014 16:30 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Feb. 6, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the Leerink...
Cellular Dynamics to Present at 32nd Annual J.P. Morgan Healthcare Conference
January 10, 2014 08:00 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Jan. 10, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), today announced that Chief Executive Officer Bob Palay is scheduled to present at the 32nd...
Cellular Dynamics Signs Agreement With Nestle Institute of Health Sciences to Supply iCell(R) and MyCell(R) Products for Nutritional Research
January 08, 2014 02:00 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Jan. 8, 2014 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced signing a long-term supply agreement with the Nestlé Institute of Health...
The Hamner Institutes and Cellular Dynamics Collaborate to Develop In Vitro Assays Using Human iPS Cell-Derived Hepatocytes
December 09, 2013 08:00 ET
|
Cellular Dynamics International, Inc.
RESEARCH TRIANGLE PARK, N.C. and MADISON, Wis., Dec. 9, 2013 (GLOBE NEWSWIRE) -- The Hamner Institutes for Health Sciences today announced a collaborative agreement with Cellular Dynamics...
Jain Foundation Signs Agreement With Cellular Dynamics to Create iPSC Lines From Patients With Muscular Dystrophies
December 04, 2013 08:00 ET
|
Cellular Dynamics International, Inc.
SEATTLE and MADISON, Wis., Dec. 4, 2013 (GLOBE NEWSWIRE) -- The Jain Foundation, a non-profit organization whose mission is to cure muscular dystrophies caused by dysferlin protein deficiency, today...
Cellular Dynamics International Reports Third Quarter 2013 Financial Results
November 12, 2013 16:05 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 12, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and manufacturer of fully functioning human cells in industrial quantities to...
Cellular Dynamics International Announces Conference Call to Discuss Third Quarter 2013 Financial and Operating Results
November 05, 2013 08:00 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 5, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) today announced that it will report third quarter 2013 financial and operating results after the...
Cellular Dynamics Receives Formal Notice of Grant Award (NGA) for $16 Million Stem Cell Banking Project
November 04, 2013 16:05 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Nov. 4, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL) announced today that the company has received the Notice of Grant Award (NGA) from the California...
Cellular Dynamics Issued U.S. Patent Covering Differentiation of iPS Cells Into Endothelial, Hematopoietic Cells
October 16, 2013 08:00 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL), announced today that the U.S. Patent and Trademark Office (PTO) issued Patent No. 8,557,580...
Cellular Dynamics Issued U.S. Patent Covering iPSC Episomal Reprogramming
October 02, 2013 08:00 ET
|
Cellular Dynamics International, Inc.
MADISON, Wis., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Cellular Dynamics International (CDI) (Nasdaq:ICEL), announced today that the U.S. Patent and Trademark Office (PTO) issued Patent No. 8,546,140...